Summary
Cardiac myocyte hypertrophy is commonly observed histologically in the hypertensive heart. Hypertrophic nuclei of myocytes are also detected in myocardial tissue. However, it is not clear whether an increase of nuclear size in myocytes indicates high DNA synthesis in hypertensive hearts. A total of 20 human hearts obtained at autopsy were studied. Following preparation of the hearts, the myocardium was weighed and total DNA content was determined biochemically. The DNA content was calculated by flow cytometry, and the structural changes of myocyte nuclei were visualized by three-dimensional (3-D) reconstruction. The percentage of myocytes in the G2M phase of the cell cycle was significandy increased in hypertensive hearts, compared with control hearts. The number of S-phase myocytes in hypertensive hearts was approximately twice that in control hearts. The 3-D myocardial nuclear size was bigger in hypertensive hearts than in control hearts. In conclusion, there were no dramatic changes of the DNA content and 3-D nuclear size, and such changes depended on remodeling of the intranuclear matrix in hypertrophic myocytes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Grossman W. 1980. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med 69:576–580.
Baba HA, Takeda A, Schmid C, Nagano M. 1996. Early proliferative changes in hearts of hypertensive Goldblatt rats: an immunohistochemical and flow-cytometrical study. Basic Res Cardiol 91:275–282.
Komuro I, Kurabayashi M, Shibazaki Y, Katoh Y, Hoh E, Kaida T, Ikeda K, Takaku F, Yazaki Y. 1990. Molecular mechanism of cardiac hypertrophy. Jpn Circ J 54:526–534.
Badeer HS. 1972. Development of cardiomegaly. A unifying hypothesis explaining the growth of muscle fiber, blood vessels and collagen of heart. Cardiology 57:247.
Hollander W. 1976. Role of hypertension in atherosclerosis and cardiovascular disease. Am J Cardiol 38:786.
Kannel WB, Castelli WP, McNamara PL, McKee PA, Feinleib M. 1972. Role of blood pressure in the development of congestive heart failure. N Engl J Med 287:784.
Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP. 1990. A molecular basis for hypertrophic cardiomyopathy. Cell 62:999–1006.
Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg HP, Seidman JG, Seidman CE. 1990. A molecular basis for familial hypertrophic cardiomyopathy. Cell 62:991–998.
Takeda A, Takeda N. 1997. Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy. J Mol Cardiol 29:2961–2965.
Takeda A, Chiba S, Iwai T, Tanamura A, Yamaguchi Y, Takeda N. 1998. Cell cycle of myocytes of cardiac and skeletal muscle in mitochondrial myopathy. Jpn Circ J 62:695–699.
Tezuka F. 1975. Muscle fiber orientation in normal and hypertrophied hearts. Tohoku J Exp Med 117:289–297.
Stephenson RA, Gay H, Fair WR. 1986. Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissue. Cytometry 7:41–44.
David W, Hedley ML, Friedlander IW, Taylor LW. 1983. Method for analysis of celluar DNA content of paraffin-embedded pathological materials using flow cytometry. J Histochem Cytochem 31:1333–1335.
David W, Hedley ML, Friedlander IW, Taylor LW. 1985. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploid and its clinical significance. Cytometry 6:327–333.
Hedley DW, Friedlander ML, Taylor LW. 1985. Application of DNA flowcytometry to paraffin-embedded archival materials for the study of aneuploid and clinical significance. Cytometry 6:327–333.
Reynder SB, Bosman MJ. 1985. Flow cytometric determination of DNA ploid level in nuclei isolated from paraffin-embedded tissue. Cytometry 6:26–30.
Fried J. 1976. Method for the quantitative evaluation of data from microfluorometry. Comput Biomed Res 9:263.
Dean PN, Jett JH. 1974. Mathematical analysis of DNA distribution derived from flow microfluorometry. J Cell Biol 60:523.
Vindelov LL, Christensen IJ, Nissen NI. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323–327.
Takeda A, Kawai S, Okada R, Nagai M, Takeda N, Nagano M. 1993. Three-dimensional distribution of myocardial fibrosis in the new J-2-N cardiomyopathic hamster: comparison with electrocardiographic findings. Heart Vessels 8:186–193.
Linzbach AJ. 1976. Hypertrophy, hyperplasia and structural dilatation of the human heart. Adv Cardiol 18:1–14.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Takeda, A., Hayashi, Y., Shikata, C., Tanaka, Y., Takeda, N. (2000). Three-Dimensional Nuclear Size and DNA Content in Hypertensive Heart Disease. In: Takeda, N., Nagano, M., Dhalla, N.S. (eds) The Hypertrophied Heart. Progress in Experimental Cardiology, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4423-4_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4423-4_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6991-2
Online ISBN: 978-1-4615-4423-4
eBook Packages: Springer Book Archive